- Home
- PAMT vs TRVI Comparison
PAMT vs TRVI Comparison
Compare PAMT & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAMT
- TRVI
- Stock Information
- Founded
- PAMT 1980
- TRVI 2011
- Country
- PAMT United States
- TRVI United States
- Employees
- PAMT N/A
- TRVI N/A
- Industry
- PAMT Trucking Freight/Courier Services
- TRVI Biotechnology: Pharmaceutical Preparations
- Sector
- PAMT Industrials
- TRVI Health Care
- Exchange
- PAMT Nasdaq
- TRVI Nasdaq
- Market Cap
- PAMT 350.7M
- TRVI 383.4M
- IPO Year
- PAMT 1985
- TRVI 2019
- Fundamental
- Price
- PAMT $12.58
- TRVI $6.50
- Analyst Decision
- PAMT Hold
- TRVI Strong Buy
- Analyst Count
- PAMT 1
- TRVI 8
- Target Price
- PAMT $16.50
- TRVI $17.56
- AVG Volume (30 Days)
- PAMT 16.8K
- TRVI 4.4M
- Earning Date
- PAMT 04-17-2025
- TRVI 03-18-2025
- Dividend Yield
- PAMT N/A
- TRVI N/A
- EPS Growth
- PAMT N/A
- TRVI N/A
- EPS
- PAMT N/A
- TRVI N/A
- Revenue
- PAMT $714,646,000.00
- TRVI N/A
- Revenue This Year
- PAMT $0.61
- TRVI N/A
- Revenue Next Year
- PAMT $10.29
- TRVI N/A
- P/E Ratio
- PAMT N/A
- TRVI N/A
- Revenue Growth
- PAMT N/A
- TRVI N/A
- 52 Week Low
- PAMT $12.21
- TRVI $2.30
- 52 Week High
- PAMT $23.70
- TRVI $7.39
- Technical
- Relative Strength Index (RSI)
- PAMT N/A
- TRVI 66.37
- Support Level
- PAMT N/A
- TRVI $6.22
- Resistance Level
- PAMT N/A
- TRVI $6.79
- Average True Range (ATR)
- PAMT 0.00
- TRVI 0.40
- MACD
- PAMT 0.00
- TRVI -0.03
- Stochastic Oscillator
- PAMT 0.00
- TRVI 52.24
About PAMT PAMT CORP Common Stock
PAMT Corp is a holding company that is engaged in providing truckload dry van carriers transporting general commodities throughout the continental United States, as well as the Canadian provinces of Ontario and Quebec.
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.